Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
53,000
Employees53,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
53,000
Employees53,000

SYK Key Statistics

Market cap
135.10B
Market cap135.10B
Price-Earnings ratio
46.99
Price-Earnings ratio46.99
Dividend yield
0.95%
Dividend yield0.95%
Average volume
1.84M
Average volume1.84M
High today
$359.95
High today$359.95
Low today
$350.32
Low today$350.32
Open price
$356.80
Open price$356.80
Volume
1.30M
Volume1.30M
52 Week high
$404.87
52 Week high$404.87
52 Week low
$329.16
52 Week low$329.16

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $353.26. The company's market cap stands at 135.1B, with a P/E ratio of 46.99 and a dividend yield of 95.0%.

During the trading session on 2026-01-29, Stryker(SYK) shares reached a daily high of $359.95 and a low of $350.32. At a current price of $353.26, the stock is +0.8% higher than the low and still -1.9% under the high.

Trading volume for Stryker(SYK) stock has reached 1.3M, versus its average volume of 1.84M.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

SYK News

Simply Wall St 2d
TD Cowen’s Valuation Downgrade Might Change The Case For Investing In Stryker

TD Cowen recently downgraded Stryker’s rating from “Buy” to “Hold,” arguing that the current share valuation already factors in potential earnings growth. The...

TD Cowen’s Valuation Downgrade Might Change The Case For Investing In Stryker
Nasdaq 2d
Strategy To YieldBoost Stryker To 8.4% Using Options

Shareholders of Stryker Corp (Symbol: SYK) looking to boost their income beyond the stock's 1% annualized dividend yield can sell the December covered call at t...

Strategy To YieldBoost Stryker To 8.4% Using Options
TipRanks 3d
Stryker transferred at Hold from Buy at TD Cowen

TD Cowen downgraded Stryker (SYK) to Hold from Buy with a $387 price target as he took over coverage. While stating that “there’s a lot we like about the story...

Analyst ratings

78%

of 32 ratings
Buy
78.1%
Hold
18.8%
Sell
3.1%

More SYK News

TipRanks 3d
Stryker: Strong Fundamentals and Growth Prospects Largely Priced In, Justifying a Hold Rating

Stryker, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen downgraded the rating on the stock to...

Simply Wall St 5d
Is Stryker Pricing In Too Much Optimism After Recent Share Price Weakness?

If you are wondering whether Stryker's current share price fairly reflects its long term potential, you are not alone. This article is here to unpack that quest...

Is Stryker Pricing In Too Much Optimism After Recent Share Price Weakness?

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.